세계의 바이오의약품 실험 기구 시장 보고서(2025년)
Biopharmaceutical Lab Equipment Global Market Report 2025
상품코드 : 1877553
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오의약품 실험 기구 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2024년 164억 4,000만 달러에서 2025년에는 177억 7,000만 달러에 달하고, CAGR 8.1%를 나타낼 것으로 전망되고 있습니다. 지난 수년간의 성장은 바이오의약품의 연구개발비 증가, 생물학적 제제 수요 증가, 만성질환 유병률 상승, 임상시험의 세계적 확대, 신약 개발투자 증가 등이 요인으로 여겨지고 있습니다.

바이오의약품 실험 기구 시장 규모는 향후 수년간 견조한 성장이 예상됩니다. 2029년에는 239억 3,000만 달러에 달하고, CAGR은 7.7%를 나타낼 전망입니다. 예측 기간 동안의 성장은 개인화된 의료의 도입 확대, 높은 처리량 스크리닝 수요 증가, 바이오 제조 효율성 향상의 중요성, 신흥 바이오의약품 기업의 확대, 고급 분석 도구의 필요성 증가로 인한 것으로 예측됩니다. 예측 기간 동안 예상되는 주요 동향으로는 실험실 자동화의 기술진보, 바이오프로세스 기기의 혁신, 분석기기의 진보, 생물학적 제제 제조에 있어서의 지속적인 연구개발, 세포 배양기술의 개선 등을 들 수 있습니다.

맞춤형 의료에 대한 관심 증가는 향후 몇 년 동안 바이오의약품 실험 기구 시장의 확대를 이끌 것으로 예측됩니다. 맞춤형 의료는 유전자·환경·생활습관의 개인차에 근거하여 치료·예방전략을 커스터마이즈하는 환자 중심의 접근입니다. 유전체 시퀀싱 기술과 데이터 분석의 진보로 의료 전문가가 환자별로 정확한 진단 도구와 표적 요법을 개발할 수 있게 된 것이 맞춤형 의료의 보급을 뒷받침하고 있습니다. 이 정밀의료로의 전환에 따라 유전자 데이터 분석, 표적 요법 개발, 개인화 치료에 대한 임상 연구를 지원하는 고급 실험 기구에 대한 수요가 높아지고 있습니다. 예를 들어 미국에 본거지를 둔 병원·의료조직 '맞춤형 의료연합'에 따르면 2024년 2월 시점에서 2023년 FDA가 승인한 희소질환 환자를 위한 신규맞춤형 치료는 16건에 이르러 2022년 6건에서 증가했습니다. 그러므로 맞춤형 의료에 대한 관심 증가는 바이오의약품 실험 기구 시장의 성장을 이끌고 있습니다.

바이오의약품 실험 기구 시장의 주요 기업은 검사 정밀도 향상, 워크플로우 효율화, 실험실 효율 강화를 목적으로 한 고분해능 질량 분석 시스템 등의 혁신적인 솔루션을 개발하고 있습니다. 고분해능 질량 분석 시스템은 이온의 질량 전하비를 고정밀도로 측정하고 복잡한 분자의 동정·정량을 실시하는 선진 장치이며, 단백질체학, 의약품, 화학 분석 등의 응용 분야를 지원하고 있습니다. 예를 들어, 2025년 6월에는 미국 생명과학기업 서모피셔 사이언티픽사가 Thermo Scientific OptiSpray 기술을 탑재한 차세대 질량 분석기를 발표했습니다. 이러한 시스템은 단백질, 대사산물 및 기타 생체분자의 검출에 탁월한 속도와 감도를 제공하여 고급 정밀의료 연구를 지원합니다. 주요 특징은 고해상도 질량 분석, 멀티오믹스 연구를 위한 최적화된 워크플로우, 데이터 처리를 위한 사용자 친화적인 소프트웨어, 샘플 처리의 강력한 자동화, 환경 및 식품 안전 연구와의 유연한 통합을 포함합니다. 이러한 혁신을 통해 연구자들은 일관되고 고품질의 데이터를 생성하고 복잡한 질병 연구에서 발견을 가속화할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Biopharmaceutical lab equipment comprises instruments and devices designed to aid in the development, testing, and analysis of biopharmaceutical products. It enables accurate measurement, control, and manipulation of biological and chemical processes. This equipment improves experimental precision and reproducibility, ensuring dependable results. Its primary role is to support efficient and high-quality research within the field of biopharmaceutical sciences.

The key product types of biopharmaceutical lab equipment include chromatography systems, mass spectrometers, polymerase chain reaction (PCR) equipment, cell culture systems, microscopes, and others. Chromatography systems are utilized to separate, identify, and purify components within complex biological mixtures, ensuring accurate analysis and production in biopharmaceutical laboratories. The technologies involved include single-use technology, continuous processing technology, cell culture technology, filtration technology, and high-throughput screening technology. Laboratories are categorized by size into small-scale, medium-scale, and large-scale labs. This equipment is used in various applications such as drug discovery, clinical diagnostics, research and development, quality control, and others, and serves multiple end-users including pharmaceutical companies, biotechnology companies, academic and research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The biopharmaceutical lab equipment market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical lab equipment market statistics, including biopharmaceutical lab equipment industry global market size, regional shares, competitors with a biopharmaceutical lab equipment market share, detailed biopharmaceutical lab equipment market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical lab equipment industry. The biopharmaceutical lab equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biopharmaceutical lab equipment market size has grown strongly in recent years. It will grow from $16.44 billion in 2024 to $17.77 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. Growth during the historic period can be attributed to rising biopharmaceutical research and development expenditure, increasing demand for biologics, a growing prevalence of chronic diseases, the global expansion of clinical trials, and rising investments in drug discovery.

The biopharmaceutical lab equipment market size is expected to see strong growth in the next few years. It will grow to $23.93 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. Growth during the forecast period is expected to be driven by the rising adoption of personalized medicine, increasing demand for high-throughput screening, a growing emphasis on enhancing biomanufacturing efficiency, the expansion of emerging biopharma companies, and the rising need for advanced analytical tools. Key trends anticipated during the forecast period include technological progress in lab automation, innovations in bioprocessing equipment, advancements in analytical instrumentation, ongoing research and development in biologics manufacturing, and improvements in cell culture technologies.

The growing focus on personalized medicine is expected to drive the expansion of the biopharmaceutical lab equipment market in the coming years. Personalized medicine is a patient-centered approach that customizes treatment and prevention strategies based on individual variations in genes, environments, and lifestyles. The increasing adoption of personalized medicine is fueled by advancements in genomic sequencing technologies and data analytics, allowing healthcare professionals to create more accurate diagnostic tools and targeted therapies for individual patients. This shift toward precision-based healthcare increases the need for advanced laboratory equipment capable of analyzing genetic data, developing targeted therapies, and supporting clinical research for individualized treatments. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, compared to six in 2022. Therefore, the growing focus on personalized medicine is driving the growth of the biopharmaceutical lab equipment market.

Major companies in the biopharmaceutical lab equipment market are developing innovative solutions such as high-resolution mass analysis systems to improve testing accuracy, streamline workflows, and enhance laboratory efficiency. A high-resolution mass analysis system is an advanced instrument that measures the mass-to-charge ratio of ions with high precision to identify and quantify complex molecules, supporting applications in proteomics, pharmaceuticals, and chemical analysis. For instance, in June 2025, Thermo Fisher Scientific, a US-based life sciences company, introduced next-generation mass spectrometry instruments featuring Thermo Scientific OptiSpray technology. These systems provide exceptional speed and sensitivity for detecting proteins, metabolites, and other biomolecules, supporting advanced precision medicine research. Key features include high-resolution mass analysis, optimized workflows for multiomics studies, user-friendly software for data processing, strong automation for sample handling, and flexible integration with environmental and food safety research. These innovations enable researchers to produce consistent, high-quality data and accelerate discoveries in complex disease research.

In July 2025, Advanced Instruments LLC, a US-based manufacturing company, acquired Nova Biomedical Corporation for an undisclosed amount. The acquisition aims to establish a global life science platform under the Nova Biomedical brand by integrating complementary technologies, expanding global presence, accelerating innovation, and providing greater value to customers in biopharmaceutical and clinical markets. This initiative is expected to enhance patient care and drive long-term sustainable growth. Nova Biomedical Corporation is a US-based technology company that provides biopharmaceutical lab equipment.

Major players in the biopharmaceutical lab equipment market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Agilent Technologies Inc., Hitachi High-Tech Corporation, Illumina Inc., Mettler-Toledo International Inc., Shimadzu Corporation, Bruker Corporation, Waters Corporation, Horiba Ltd., Eppendorf SE, Tecan Group Ltd., Hamilton Company, Oxford Instruments plc, Telstar SA, Advanced Instruments LLC, PBS Biotech Inc., Logos Biosystems Inc., Napro Scientific Inc., and Accumax Lab Devices Pvt. Ltd.

North America was the largest region in the biopharmaceutical lab equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biopharmaceutical lab equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biopharmaceutical lab equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical lab equipment market consists of sales of centrifuges, bioreactors, incubators, autoclaves, spectrophotometers, freezers, pipettes, microplate readers, liquid handling robots, analytical balances, and biosafety cabinets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Lab Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical lab equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biopharmaceutical lab equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopharmaceutical lab equipment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Biopharmaceutical Lab Equipment Market Characteristics

3. Biopharmaceutical Lab Equipment Market Trends And Strategies

4. Biopharmaceutical Lab Equipment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biopharmaceutical Lab Equipment Growth Analysis And Strategic Analysis Framework

6. Biopharmaceutical Lab Equipment Market Segmentation

7. Biopharmaceutical Lab Equipment Market Regional And Country Analysis

8. Asia-Pacific Biopharmaceutical Lab Equipment Market

9. China Biopharmaceutical Lab Equipment Market

10. India Biopharmaceutical Lab Equipment Market

11. Japan Biopharmaceutical Lab Equipment Market

12. Australia Biopharmaceutical Lab Equipment Market

13. Indonesia Biopharmaceutical Lab Equipment Market

14. South Korea Biopharmaceutical Lab Equipment Market

15. Western Europe Biopharmaceutical Lab Equipment Market

16. UK Biopharmaceutical Lab Equipment Market

17. Germany Biopharmaceutical Lab Equipment Market

18. France Biopharmaceutical Lab Equipment Market

19. Italy Biopharmaceutical Lab Equipment Market

20. Spain Biopharmaceutical Lab Equipment Market

21. Eastern Europe Biopharmaceutical Lab Equipment Market

22. Russia Biopharmaceutical Lab Equipment Market

23. North America Biopharmaceutical Lab Equipment Market

24. USA Biopharmaceutical Lab Equipment Market

25. Canada Biopharmaceutical Lab Equipment Market

26. South America Biopharmaceutical Lab Equipment Market

27. Brazil Biopharmaceutical Lab Equipment Market

28. Middle East Biopharmaceutical Lab Equipment Market

29. Africa Biopharmaceutical Lab Equipment Market

30. Biopharmaceutical Lab Equipment Market Competitive Landscape And Company Profiles

31. Biopharmaceutical Lab Equipment Market Other Major And Innovative Companies

32. Global Biopharmaceutical Lab Equipment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biopharmaceutical Lab Equipment Market

34. Recent Developments In The Biopharmaceutical Lab Equipment Market

35. Biopharmaceutical Lab Equipment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기